ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.63416
0.02%
Brent Oil
76.345
-0.21%
Bitcoin
98,444.69
0.14%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Ultragenyx Pharmaceutical Inc (0LIF) Cotización

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc (0LIF)

LSE
64.79
0.00
(0.00%)
Cerrado 05 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
64.79
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
854
0.00 Rango del Día 0.00
64.79 Rango de 52 semanas 64.79
Capitalización de Mercado [m]
5.32B
Precio Anterior
64.79
Precio de Apertura
-
Hora
1
@
41.58
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
582
Acciones en circulación
82,114,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.62
Beneficio por acción (BPA)
-7.39
turnover
434.25M
Beneficio neto
-606.64M

Acerca de Ultragenyx Pharmaceutical Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.ultragenyx.com
Sede
Wilmington, Delaware, USA
Fundado
-
Ultragenyx Pharmaceutical Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0LIF. The last closing price for Ultragenyx Pharmaceutical was US$64.79. Over the last year, Ultragenyx Pharmaceutical shares have traded in a share price range of US$ 64.79 to US$ 64.79.

Ultragenyx Pharmaceutical currently has 82,114,000 shares in issue. The market capitalisation of Ultragenyx Pharmaceutical is US$5.32 billion. Ultragenyx Pharmaceutical has a price to earnings ratio (PE ratio) of -5.62.

0LIF Últimas noticias

Más noticias

NHS England Rolls Out Evkeeza® ▼(evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH)

NHS England Rolls Out Evkeeza® ▼(evinacumab) for Eligible Adults and Adolescents Aged 12 Years and Older with Homozygous Familial Hypercholesterolaemia (HoFH) LONDON, Dec. 20, 2024 (GLOBE...

20 Diciembre 2024
UK Regulatory

Ultragenyx presenta Evkeeza® (concentrado de evinacumab para solución para infusión) en España para el tratamiento de la hipercolesterolemia familiar homocigótica (HFho)

Ultragenyx presenta Evkeeza® (concentrado de evinacumab para solución para infusión) en España para el tratamiento de la hipercolesterolemia familiar homocigótica (HFho) Evkeeza es un medicamento...

03 Septiembre 2024
UK Regulatory

Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)

Ultragenyx Receives Positive Recommendation from NICE in the U.K. for Evkeeza® ▼ (evinacumab) for Adolescents and Adults Aged 12 Years and Older with Homozygous Familial Hypercholesterolemia...

04 Enero 2024
GlobeNewswire Inc.

Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH)

Ultragenyx Receives European Commission Decision for Evkeeza® (evinacumab) Expanded Indication in Children Aged 5 Years and Older with Homozygous Familial Hypercholesterolemia (HoFH) For the...

18 Diciembre 2023
GlobeNewswire Inc.

Ultragenyx lancia in Italia Evkeeza® (evinacumab concentrato in soluzione per infusione) per il trattamento dell’ipercolesterolemia familiare omozigote (HoFH)

Ultragenyx lancia in Italia Evkeeza® (evinacumab concentrato in soluzione per infusione) per il trattamento dell’ipercolesterolemia familiare omozigote (HoFH) Evkeeza è un farmaco, primo nel...

06 Noviembre 2023
GlobeNewswire Inc.

Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein

Zur Behandlung der homozygoten familiären Hypercholesterinämie (HoFH): Ultragenyx führt Evkeeza® (Evinacumab) in Deutschland ein Evkeeza® ist das erste von der U.S. Food and Drug...

01 Septiembre 2023
GlobeNewswire Inc.

MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Italy

MEDIA ADVISORY: Ultragenyx Announces Mepsevii® (vestronidase alfa) Receives Reimbursement Approval for Treatment of Mucopolysaccharidosis VII in Italy NOVATO, Calif., Sept. 09, 2021 (GLOBE...

09 Septiembre 2021
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10064.7964.7964.793464.79DE
40064.7964.7964.7924964.79DE
120064.7964.7964.7958264.79DE
260064.7964.7964.7939064.79DE
520064.7964.7964.7932664.79DE
1560064.7964.7964.7950664.79DE
2600064.7964.7964.7931964.79DE

0LIF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ultragenyx Pharmaceutical?
El precio actual de las acciones de Ultragenyx Pharmaceutical es US$ 64.79
¿Cuántas acciones de Ultragenyx Pharmaceutical están en circulación?
Ultragenyx Pharmaceutical tiene 82,114,000 acciones en circulación
¿Cuál es la capitalización de mercado de Ultragenyx Pharmaceutical?
La capitalización de mercado de Ultragenyx Pharmaceutical es USD 5.32B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical ha negociado en un rango de US$ 64.79 a US$ 64.79 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ultragenyx Pharmaceutical?
El ratio precio/beneficio de Ultragenyx Pharmaceutical es -5.62
¿Cuál es el ratio de efectivo a ventas de Ultragenyx Pharmaceutical?
El ratio de efectivo a ventas de Ultragenyx Pharmaceutical es 7.85
¿Cuál es la moneda de reporte de Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Ultragenyx Pharmaceutical?
El último ingresos anual de Ultragenyx Pharmaceutical es USD 434.25M
¿Cuál es el último beneficio anual de Ultragenyx Pharmaceutical?
El último beneficio anual de Ultragenyx Pharmaceutical es USD -606.64M
¿Cuál es la dirección registrada de Ultragenyx Pharmaceutical?
La dirección registrada de Ultragenyx Pharmaceutical es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Ultragenyx Pharmaceutical?
La dirección del sitio web de Ultragenyx Pharmaceutical es www.ultragenyx.com
¿En qué sector industrial opera Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discusión

Ver feed completo
barnyarddog barnyarddog 34 segundos hace
GCTS - Semiconductor signs MOU with Samsung to accelerate the development of 4G/5G chipsets and modules

SAN JOSE, CA – August 13, 2024
https://www.gctsemi.com/samsung-pr-august-13-2024

July 23, 2024 GCT Semiconductor and Ligado Networks Announce Commercial Availa
AITX GCT GCTS
barnyarddog barnyarddog 50 segundos hace
GCTS - Semiconductor signs MOU with Samsung to accelerate the development of 4G/5G chipsets and modules

SAN JOSE, CA – August 13, 2024
https://www.gctsemi.com/samsung-pr-august-13-2024

July 23, 2024 GCT Semiconductor and Ligado Networks Announce Commercial Availa
AITX GCT GCTS
aljafy aljafy 2 minutos hace
Yeah, this is one I held through tax-selling. This can move real hard real fast.
TCRI
Koog Koog 2 minutos hace
An excerpt from The Nvidia Way: Jensen Huang and the Making of a Tech Giant by Tae Kim, quoting Gelsinger:

“As for GPUs, current Intel CEO Pat Gelsinger laments that the company failed to break into the category with its own in-house product that would have competed with Nvidia’s. “I
INTC
Eagle1 Eagle1 2 minutos hace
GDVM is my favorite OTC.

Anyone who loves me give me a follow.

Thanks benzE for following me.

Much loves.

Eagle1 Over and Out.
GDVM
stay long stay long 2 minutos hace
Elon Musk will pivot to hydrogen in 2026. He is smart enough to recognize the trend to hydrogen.
FCEL
TightCoil TightCoil 2 minutos hace
Tremble with Fear for tomorrow's
trading, Mr. Krab; Tremble with Fear
FNMA
HappyLibrarian HappyLibrarian 4 minutos hace
As will I... lol. Amazing to be back at a share price where we will be grateful to get to a buck

After more than 11 years invested in NWBO getting to 1 dollar a share with TLD already in the rear view mirror is not much to be amazed at or grateful for. It is far less than we have the
NWBO
15for2 15for2 4 minutos hace
thanks for that, it explains the drop,
looks as they are done so it should be good if the interest returns imo~
LITM
Docsavag Docsavag 4 minutos hace
Did you leave out world hunger on purpose, as the US seems to bear responsibility for everything...??
LEHNQ
m0n m0n 5 minutos hace
Why a Canadian Stock Exchange halt affects a USA company trading OTC in the USA is cra cra 

$TWOH
TWOH
Hopeforthefuture3 Hopeforthefuture3 5 minutos hace
Me too, I will be very pleased to see a quote at a dollar or more (even if 1 dollar) rather than in pennies and with4 and sometime 5 places after the decimal. Hard (or shameful) to think I bought this as high as $10/share (and yes I did)
NWBO
DrSleep DrSleep 5 minutos hace
What ramifications could this hold for elite? Financial compensation? Etc?
ELTP
Viking61 Viking61 6 minutos hace
Rick , do you have a kick starter on that whale horn??
FNMA
MartinLutherKing MartinLutherKing 6 minutos hace
Will they get an FDA fast track status for terminally ill cancer patients
https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors
barnyarddog barnyarddog 6 minutos hace
About us


GCT Semiconductor is a leading fabless designer and supplier of advanced 4G LTE semiconductor solutions. GCT’s market-proven LTE solutions enable fast and reliable LTE connectivity to wireless devices such as smartphones, tablets, hotspots, USB dongles,
GCT
tdbowieknife tdbowieknife 6 minutos hace
I just checked Sedar and still nothing filed. I know they could if they tried as there have been 6 other disclosure docs filed Today. Some of them PR's a few Material change.

.
TWOH
kid70 kid70 7 minutos hace
I wish JB would actually give you something new to report on.  You are reporting on old and false news.   Kevin is working for another company and Kevin has sold the building 
UBQU
Lime Time Lime Time 7 minutos hace
Very nice. Gonna be a good one VGTL
VGTL
ron_66271 ron_66271 8 minutos hace
Marty Only has Two Weeks to Complete His Tasks.

Too control the narrative.
You do the math?!

Remember that JPM and the FDIC Lost in DC Court.
DOCUMENTED!



Ron
JPM
trunkmonk trunkmonk 8 minutos hace
Light took a guess where Carney was by a pic he posted, CarneyClown is on Jekyll island, his clue was a pic of drift wood on the beach, it was as cryptic and lacking in background, its something only Carney could think we all have time to figure out 10,000 places on earth just to see where he is. wh
FNMA
Lifetime Lifetime 8 minutos hace
You know that is not based in reality. Shameful.
jour_trader jour_trader 9 minutos hace
There is one patent (434 patent) that Purdue claimed against Accord that I don't see a ruling on. This is against Elite too. 

4 of these patents have been filed against Abai and KVK-Tech. Another filed against Amneal and Kashiv. 

There are 2 patents where Elite stands a
ELTP
barnyarddog barnyarddog 9 minutos hace
GCTS - Semiconductor signs MOU with Samsung to accelerate the development of 4G/5G chipsets and modules

SAN JOSE, CA – August 13, 2024
https://www.gctsemi.com/samsung-pr-august-13-2024

July 23, 2024 GCT Semiconductor and Ligado Networks Announce Commercial Avai
GCT GCTS

Su Consulta Reciente

LSE
0LIF
Ultragenyx Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados